SCHEMBL3785846

SCHEMBL3785846

Cc1nc(Cl)nc(-n2c(Cl)nc3cc(F)c(F)cc32)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.45
PIK3CA P42336 1/20 0.45
PIK3CB P42338 1/20 0.45
MTOR P42345 1/20 0.45
PIK3CG P48736 1/20 0.45
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
XBP1 P17861 1/20 0.36
MAPK1 P28482 1/20 0.36
RAB9A P51151 1/20 0.36
ATM Q13315 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ALOX15 P16050 1/20 0.36
HTT P42858 1/20 0.36
CYP11B2 P19099 12/20 0.35
CYP11B1 P15538 7/20 0.33
CYP3A4 P08684 1/20 0.31
CCNT1 O60563 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3790546 0.77 TP53 (0.37) PIK3CDPIK3CAPIK3CBPIK3CGMAPT
SCHEMBL3787311 0.77 NPM1 (0.39) MAPTMAPK1RAB9ASMN1; SMN2ALOX15
SCHEMBL3795141 0.76 SMN1; SMN2 (0.50) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL9980836 0.69 ALOX15 (0.58) KDM4ELMNAPOLBMAPTXBP1
SCHEMBL16739721 0.64 CYP11B2 (0.40) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL10642137 0.63 ALOX15 (0.59) KDM4ELMNAPOLBMAPTXBP1
SCHEMBL3789860 0.62 PIK3CD (0.44) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL3789399 0.62 PIK3CD (0.44) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL3711360 0.62 MTOR (0.62) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL6740559 0.60 NR1H4 (0.37) KDM4ELMNAPOLBMAPTXBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120165334-A1 Indole/Benzimidazole Compounds as mTOR Kinase Inhibitors AMGEN INC. (US) 2012-06-28 US disclosed
EP-2398791-A1 INDOLE/BENZIMIDAZOLE COMPOUNDS AS mTOR KINASE INHIBITORS Amgen, Inc (US) 2011-12-28 EP disclosed
WO-2010096314-A1 INDOLE/BENZIMIDAZOLE COMPOUNDS AS mTOR KINASE INHIBITORS AMGEN INC. (US) 2010-08-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120165334-A1 Indole/Benzimidazole Compounds as mTOR Kinase Inhibitors MTOR, PIKFYVE, RICTOR PIK3CD 8/4885PIK3CA 9/4885PIK3CB 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.